Beta Bionics, Inc Common Stock

Beta Bionics, Inc Common Stock

Yahoo Finance • 8 days ago

Beta Bionics expects $124M-$126M 2026 revenue and targets Mint launch in Q1 2027

Earnings Call Insights: Beta Bionics (BBNX) Q3 2026 MANAGEMENT VIEW * "In September, we received FDA clearance for Mint, our transformative patch pump, which we expect to fully commercialize in the U.S. in Q1 of 2027." (President, CEO... Full story

Yahoo Finance • 25 days ago

Barclays Says MedTech Stocks Are at Their Cheapest in a Decade — and Names 2 Stocks to Buy

Medical technology has been changing human life for centuries. This is especially true for patients dealing with the long-term lifestyle impacts of acute and chronic conditions. Diseases such as diabetes, Crohn's, and cancer, or severe ort... Full story

Yahoo Finance • 27 days ago

Beta Bionics (BBNX) Stock Fair Value Rises After Mint Clearance And Analyst Target Changes

Beta Bionics now carries an updated fair value estimate of US$23.80 per share, up from about US$21.67, which refines how analysts frame the stock's long term potential. This reset fits with recent commentary that weighs the Mint patch pump... Full story

Yahoo Finance • 4 months ago

Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders

SAN DIEGO, June 29, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certai... Full story

Yahoo Finance • 5 months ago

Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth

SAN DIEGO, June 11, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certai... Full story

Yahoo Finance • 5 months ago

Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information

SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breache... Full story

Yahoo Finance • 5 months ago

Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws

SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breache... Full story

Yahoo Finance • 6 months ago

Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5%

Earnings Call Insights: Beta Bionics (BBNX) Q1 2026 MANAGEMENT VIEW * "We're pleased to share with you all today our financial results for the first quarter as well as positive updates to our full year guidance for 2026." (President, C... Full story

Yahoo Finance • 7 months ago

Quant snapshot: Eni, Alpine Income Property Trust lead top-rated names as Crown Castle, Goosehead Insurance lag

Quant rankings for the upcoming earnings calendar show strength concentrated across energy, financials, and materials, while weakness is more pronounced in real estate, financials, and pockets of healthcare and information technology. A to... Full story

Yahoo Finance • 7 months ago

Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026

IRVINE, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2026 finan... Full story

Yahoo Finance • 8 months ago

ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses Beta Bionics Stock or Options To Contact Him Directly At877-247-4292 or 212-983-9330 (Ext. 1310). [You may also cl... Full story

Yahoo Finance • 8 months ago

BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Beta Bionic... Full story

Yahoo Finance • 8 months ago

Lowest Quant ranked small-cap stocks with positive EPS surprises

[Wall street sign on manhattan] franckreporter/iStock via Getty Images With the Q4 earnings season almost coming to an end, below is a list of small-cap stocks with positive quarterly EPS surprises ranked according to their lowest Seeking... Full story

Yahoo Finance • 8 months ago

Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Beta Bionics, Inc. (Nasdaq: BBNX) for potential securities law violations. Investors who have lost money in their Beta Bionics, Inc. investment should contact the... Full story

Yahoo Finance • 9 months ago

BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in B... Full story

Yahoo Finance • 9 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 9 months ago

Beta Bionics GAAP EPS of -$0.30 beats by $0.10, revenue of $32.1M beats by $1.03M

* Beta Bionics press release [https://seekingalpha.com/pr/20402602-beta-bionics-announces-fourth-quarter-and-full-year-2025-financial-results-and-introduces] (BBNX [https://seekingalpha.com/symbol/BBNX]): Q4 GAAP EPS of -$0.30 beats by $... Full story

Yahoo Finance • 9 months ago

Oracle gets upgrade and downgrade: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Roth Capital upgraded Roblox (RBLX) to... Full story

Yahoo Finance • 9 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 11 months ago

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topli... Full story